This is a single-center, randomized, open-label study to evaluate the pharmacokinetics of CM310 in healthy subjects.
This study includes screening and treatment and follow-up periods.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
236
CM310 injection
The Second Hospital of Anhui Medical University
Hefei, Anhui, China
Pharmacokinetic: the maximum concentration (Cmax)
Concentration and exposure
Time frame: up to week 6
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.